AccessPak for HIV PEP Expanded with Kaletra and Risedronate Delayed-Release Tablets
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Risedronate Delayed-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: risedronate
Brand name: Actonel, Atelvia
Synonyms: Risedronate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Risedronate Sodium
- AccessPak for HIV PEP Expanded with Kaletra-Risedronate Tablets
- AccessPak for HIV PEP Expanded with Kaletra-Risperdal
- AccessPak for HIV PEP Expanded with Kaletra-Risperdal (Risperidone Oral Solution)
- AccessPak for HIV PEP Expanded with Kaletra-Risperdal (Risperidone Tablets)
- AccessPak for HIV PEP Expanded with Kaletra-Risperdal Consta
- Risedronate Delayed-Release Tablets-AccessPak for HIV PEP Expanded with Viracept
- Risedronate Delayed-Release Tablets-Accolate
- Risedronate Delayed-Release Tablets-Accretropin
- Risedronate Delayed-Release Tablets-Accucaine
- Risedronate Delayed-Release Tablets-AccuHist Drops
- Risedronate Delayed-Release Tablets-AccuHist PDX Drops